BioXcel Therapeutics is a clinical stage biopharmaceutical company that utilizes state-of-the-art AI technology to identify new medicines in neuroscience and immuno-oncology. BioXcel Therapeutics has developed an innovative AI platform that combines big data and machine learning algorithms to develop drug candidates that have a greater likelihood of clinical and regulatory success. They aim to reduce the time and expense associated with drug development to benefit those with unmet medical needs.